Published in Cancer Weekly, June 12th, 2001
Primary liver cancer, also known as hepatocellular carcinoma (HCC), is one of the most common forms of cancer in the world, particularly in regions of viral hepatitis endemicity. The results of this study, which show the protein complex COX-2 is upregulated in well-differentiated HCC, may mean patients with certain types of HCC could some day be treated with COX-2 inhibitors, which are already being used to treat other illnesses.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.